AMULET PHARMACEUTICALS, INC.

Company Information

Company Name
AMULET PHARMACEUTICALS, INC.
Address
AMULET PHARMACEUTICALS, INC.
9430 Key West Avenue
Rockville, MD, 20850
Phone
n/a
URL
n/a
DUNS
148048460
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$783,970.00
6
SBIR Phase II
$472,075.00
1
Chart code to be here

Award List

  1. THE ELFL PROTEIN AS A NOVEL ANTIFUNGAL TARGET

    Amount: $99,918.00

    Not Available The Institute for Laser Technology (ILT), as the prime contractor, the University of Southern California Center for Laser Studies (USC-CLS) and Raytheon Systems Company, as subcontracto ...

    SBIR Phase I 1999 Department of Health and Human Services
  2. HISTIDINE KINASE ASSAY FOR DISCOVERY OF NEW ANTIFUNGALS

    Amount: $99,558.00

    Not Available Laser weapon systems currently under development, such as the Airborne Laser (ABL), must successfully fire laser beams over long horizontal paths through the atmosphere. Pointing the la ...

    SBIR Phase I 1999 Department of Health and Human Services
  3. METHOD FOR STERILIZATION OF HUMAN PLASMA AND PLATELETS

    Amount: $99,700.00

    N/A

    SBIR Phase I 1999 Department of Health and Human Services
  4. A method for sterilization of human plasma and platelets

    Amount: $0.00

    DESCRIPTION (provided by applicant): This proposal is to develop a method to prolong the shelf-life and increase the safety of human platelets with a unique method of sterilization. The m ...

    SBIR Phase I 2001 Department of Health and Human Services
  5. A method for sterilization of human plasma and platelets

    Amount: $472,075.00

    DESCRIPTION (provided by applicant): This proposal is to develop a method to prolong the shelf-life and increase the safety of human platelets with a unique method of sterilization. The m ...

    SBIR Phase II 2001 Department of Health and Human Services
  6. Biofilm development and Eye Infections

    Amount: $117,240.00

    Contact lens related eye infections impact millions of people yearly. Standard guidelines for lens care can minimize eye infection, but it has been shown that only about 50% of lens wearers adhere to ...

    SBIR Phase I 2005 Department of Health and Human Services
  7. Treatment of diabetic gastroparesis with nitric oxide

    Amount: $367,554.00

    DESCRIPTION (provided by applicant): This proposal will establish proof of concept for the use of nitric oxide (NO) as an effective treatment for diabetic gastroparesis. The NO will be delivered using ...

    SBIR Phase I 2007 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government